Prof. Dr. Erem Bilensoy from the Department of Pharmaceutical Technology, has been awarded a grant under TÜBİTAK BİDEB 2247-A National Outstanding Researchers Programme with her project titled “Overcoming drug resistance and enhancement of therapeutic efficacy with membrane cholesterol and LDL targeted cyclodextrin-gold nanoparticles: triple negative breast cancer and EBV-induced gastric cancer models”